Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wormwood vaginal cream for sexual function in postmenopausal women
IRCT20210223050471N2Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2022
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in female sexual dysfunction (FSD) and None comparing Artemisia absinthium vaginal cream with Placebo cream (2 arms). Primary endpoints: Sexual function, Sexual satisfaction and 1 more. Started Feb 2022; status: completed.
02
Drugs
artemisia absinthium pollen extract
03
Conditions
female sexual dysfunction (FSD)
Beyond the preview
Go deeper on IRCT20210223050471N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210223050471N2.